Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingre Lijie external formula is a Traditional Chinese Medicine (TCM) botanical preparation used topically to manage hand-foot skin reaction (HFSR) and hand-foot syndrome (HFS) in patients receiving targeted anticancer therapies, such as sorafenib. Developed primarily by researchers at Longhua Hospital, the formula is designed to clear heat and resolve dampness, addressing the erythema, edema, pain, and skin cracking associated with chemotherapy-induced skin toxicities. It is typically administered as a warm solution for soaking the hands and feet. Clinical evaluation has focused on its ability to reduce the grade of skin toxicity and delay the onset of severe symptoms, thereby supporting the continuation of primary oncological treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingre Lijie external formula.